Literature DB >> 12120213

Growth factors in pancreatic health and disease.

P Balaz1, H Friess, M W Büchler.   

Abstract

In this article the role of different growth factors and their receptors in the pathogenesis of chronic pancreatitis and pancreatic cancer is discussed. The expression of members of the epidermal growth factor family, the fibroblast growth factor family, the transforming growth factor-beta family, the platelet-derived growth factor family, the nerve growth factor family, the insulin-like growth factor family and their signaling receptors is presented, and a correlation of the molecular data with clinical and pathological changes is performed. A number of these growth factors and their receptors are markedly overexpressed in chronic pancreatitis and pancreatic cancer. In chronic pancreatitis, overexpression of growth factors and their receptors contributes to tissue remodeling and fibrogenesis. In contrast to chronic pancreatitis, pancreatic cancer is associated with a variety of genetic alterations, including mutations in tumor suppressor genes and cell cycle regulators. In the presence of these genetic disturbances, enhanced expression of growth factors and their receptors contributes to cell proliferation and enhances the aggressiveness of pancreatic cancer cells. In summary, growth factors and their receptors are often altered in chronic pancreatitis and pancreatic cancer and contribute to various pathogenetic aspects in these disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12120213     DOI: 10.1159/000055833

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  7 in total

1.  Pleuropancreatic fistulae: specialist center management.

Authors:  A Z Khan; R Ching; G Morris-Stiff; R England; M B Sherridan; A M Smith
Journal:  J Gastrointest Surg       Date:  2008-10-30       Impact factor: 3.452

2.  Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma.

Authors:  I Esposito; M Menicagli; N Funel; F Bergmann; U Boggi; F Mosca; G Bevilacqua; D Campani
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

Review 3.  Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge.

Authors:  Wasia Rizwani; Amanda E Allen; Jose G Trevino
Journal:  Cancers (Basel)       Date:  2015-09-03       Impact factor: 6.639

Review 4.  Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment.

Authors:  Kishore Polireddy; Qi Chen
Journal:  J Cancer       Date:  2016-07-07       Impact factor: 4.207

Review 5.  Implications of growth factor alterations in the treatment of pancreatic cancer.

Authors:  Márk Juhász; Barbara Nitsche; Peter Malfertheiner; Matthias P A Ebert
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

Review 6.  Pathways for aberrant angiogenesis in pancreatic cancer.

Authors:  M Korc
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

7.  Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer.

Authors:  Tomohiro Miwa; Toshio Kokuryo; Yukihiro Yokoyama; Junpei Yamaguchi; Masato Nagino
Journal:  Cancer Med       Date:  2015-04-27       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.